IPO

The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…

Signalling growing stress in India's startup ecosystem, one source said PharmEasy, backed by big-name investors such as Prosus,…

The offer is being made through the book building process, wherein not more than 50 per cent of the offer shall be available for…

The firm, which filed its preliminary IPO papers with Sebi between December 2021 and March 2022, obtained Sebi's observations…

The company had filed its draft prospectus in December 2021

Proceeds from the fresh issue would be used towards funding capital expenditure requirements for expansion of the company's Dahej…

Recognises the use of IPRs as a strategic tool in commerce and industry

Will the bullish response to last year's IPOs in the pharma and healthcare sector spur more companies to test the market in 2016?…

The price band for the offer has been fixed between Rs 240 and Rs. 250 per equity share of Rs 10 each

Foreign investment limit raised to 44 per cent